Clayman M D, Sun M J, Michaud L, Brill-Dashoff J, Riblet R, Neilson E G
Department of Medicine, University of Pennsylvania School of Medicine, Philadelphia 19104.
J Exp Med. 1988 Apr 1;167(4):1296-312. doi: 10.1084/jem.167.4.1296.
Experimental anti-tubular basement membrane (anti-TBM) disease is an autoimmune interstitial nephritis elicited in susceptible rodents after immunization with renal tubular antigen. The nephritogenic antigen in the immunizing preparation is 3M-1, a 48,000 Mr noncollagenous glycoprotein. The hallmarks of the renal lesion are the presence of anti-TBM antibodies (anti-TBM-Ab) and a dense mononuclear cell infiltrate. The anti-TBM B cell repertoire in this disease was analyzed using a library of 22 anti-TBM mAbs generated in a prototypically susceptible Brown Norway rat. These anti-TBM mAbs were all demonstrated to be 3M-1 specific and their characterization formed the basis for the following observations: (a) The size of the anti-TBM B cell population is estimated at 58 distinct clones; (b) by competitive inhibition criteria, all anti-TBM mAbs recognize the same (or spatially close) epitope(s) on 3M-1. This focused recognition was maintained in spite of considerable variability in affinity. Epitopic dominance could also be demonstrated in human polyclonal anti-TBM antisera from a patient with anti-TBM disease; and (c) a crossreactive idiotype was documented, and antisera directed toward this set of variable region determinants was shown to be effective as a prophylactic regimen to abrogate disease, and as a therapeutic modality to arrest the progression of disease; (d) analysis of VH gene families suggested biased usage of Q52- and 7183-like families, although at least three gene families are used in the anti-TBM-Ab response. Thus, the anti-TBM B cell compartment in BN rats is moderately large, but is primarily focused to a single epitope on the nephritogenic antigen and is associated with a disease-modifying crossreactive idiotype.
实验性抗肾小管基底膜(抗-TBM)病是一种自身免疫性间质性肾炎,在易感啮齿动物经肾小管抗原免疫后诱发。免疫制剂中的致肾炎抗原是3M-1,一种分子量为48,000的非胶原糖蛋白。肾脏病变的特征是存在抗-TBM抗体(抗-TBM-Ab)和密集的单核细胞浸润。使用在典型易感的棕色挪威大鼠中产生的22种抗-TBM单克隆抗体库分析了该疾病中的抗-TBM B细胞库。这些抗-TBM单克隆抗体均被证明对3M-1具有特异性,其特性构成了以下观察结果的基础:(a)抗-TBM B细胞群体的大小估计为58个不同的克隆;(b)根据竞争抑制标准,所有抗-TBM单克隆抗体识别3M-1上相同(或空间上接近)的表位。尽管亲和力存在相当大的变异性,但这种集中识别得以维持。在一名抗-TBM病患者的人多克隆抗-TBM抗血清中也可证明表位优势;(c)记录到一种交叉反应独特型,针对这组可变区决定簇的抗血清被证明作为预防方案可消除疾病,作为治疗方式可阻止疾病进展;(d)VH基因家族分析表明Q52-和7183样家族的使用存在偏差,尽管在抗-TBM-Ab反应中至少使用了三个基因家族。因此,BN大鼠中的抗-TBM B细胞区室中等大小,但主要集中于致肾炎抗原上的单个表位,并与一种可改变疾病的交叉反应独特型相关。